Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry.

Wildsmith KR, Han B, Bateman RJ.

Anal Biochem. 2009 Dec 1;395(1):116-8. doi: 10.1016/j.ab.2009.07.049. Epub 2009 Aug 3.

2.

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

Hirtz C, Vialaret J, Nouadje G, Schraen S, Benlian P, Mary S, Philibert P, Tiers L, Bros P, Delaby C, Gabelle A, Lehmann S.

Clin Chim Acta. 2016 Feb 15;454:33-8. doi: 10.1016/j.cca.2015.12.020. Epub 2015 Dec 19.

PMID:
26707914
3.

Mass spectrometry-based protein footprinting characterizes the structures of oligomeric apolipoprotein E2, E3, and E4.

Gau B, Garai K, Frieden C, Gross ML.

Biochemistry. 2011 Sep 27;50(38):8117-26. doi: 10.1021/bi200911c. Epub 2011 Sep 2.

4.

Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo.

Dieckmann M, Beil FT, Mueller B, Bartelt A, Marshall RP, Koehne T, Amling M, Ruether W, Cooper JA, Humphries SE, Herz J, Niemeier A.

J Bone Miner Res. 2013 Feb;28(2):236-45. doi: 10.1002/jbmr.1757.

5.

15N-labeled full-length apolipoprotein E4 as an internal standard for mass spectrometry quantification of apolipoprotein E isoforms.

Wang M, Chen J, Turko IV.

Anal Chem. 2012 Oct 2;84(19):8340-4. doi: 10.1021/ac3018873. Epub 2012 Sep 11.

6.

Absolute quantitation of protein posttranslational modification isoform.

Yang Z, Li N.

Methods Mol Biol. 2015;1306:105-19. doi: 10.1007/978-1-4939-2648-0_8.

PMID:
25930697
7.

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.

Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM.

Acta Neuropathol. 2014 May;127(5):633-43. doi: 10.1007/s00401-014-1266-2. Epub 2014 Mar 15.

PMID:
24633805
8.

Stable isotope labeling tandem mass spectrometry (SILT): integration with peptide identification and extension to data-dependent scans.

Elbert DL, Mawuenyega KG, Scott EA, Wildsmith KR, Bateman RJ.

J Proteome Res. 2008 Oct;7(10):4546-56. doi: 10.1021/pr800386u. Epub 2008 Sep 6.

9.

Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.

Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, Mitani A, Joyner D, Thyssen DH, Bacskai BJ, Frosch MP, Spires-Jones TL, Finn MB, Holtzman DM, Hyman BT.

J Neurosci. 2012 Oct 24;32(43):15181-92. doi: 10.1523/JNEUROSCI.1542-12.2012.

10.

Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms.

Martínez-Morillo E, Nielsen HM, Batruch I, Drabovich AP, Begcevic I, Lopez MF, Minthon L, Bu G, Mattsson N, Portelius E, Hansson O, Diamandis EP.

J Proteome Res. 2014 Feb 7;13(2):1077-87. doi: 10.1021/pr401060x. Epub 2014 Jan 14.

PMID:
24392642
11.

Chemical cross-linking/mass spectrometry maps the amyloid β peptide binding region on both apolipoprotein E domains.

Deroo S, Stengel F, Mohammadi A, Henry N, Hubin E, Krammer EM, Aebersold R, Raussens V.

ACS Chem Biol. 2015 Apr 17;10(4):1010-6. doi: 10.1021/cb500994j. Epub 2015 Jan 21.

PMID:
25546376
12.

Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.

Rapp A, Gmeiner B, Hüttinger M.

Biochimie. 2006 May;88(5):473-83. Epub 2005 Nov 15.

PMID:
16376010
13.
14.

APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice.

Sharman MJ, Morici M, Hone E, Berger T, Taddei K, Martins IJ, Lim WL, Singh S, Wenk MR, Ghiso J, Buxbaum JD, Gandy S, Martins RN.

J Alzheimers Dis. 2010;21(2):403-9. doi: 10.3233/JAD-2010-100141.

15.

Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice.

DeMattos RB, Brendza RP, Heuser JE, Kierson M, Cirrito JR, Fryer J, Sullivan PM, Fagan AM, Han X, Holtzman DM.

Neurochem Int. 2001 Nov-Dec;39(5-6):415-25.

PMID:
11578777
16.
17.

Isoform-specific proteolysis of apolipoprotein-E in the brain.

Elliott DA, Tsoi K, Holinkova S, Chan SL, Kim WS, Halliday GM, Rye KA, Garner B.

Neurobiol Aging. 2011 Feb;32(2):257-71. doi: 10.1016/j.neurobiolaging.2009.02.006. Epub 2009 Mar 10.

PMID:
19278755
18.

Constrained selected reaction monitoring: quantification of selected post-translational modifications and protein isoforms.

Liu X, Jin Z, O'Brien R, Bathon J, Dietz HC, Grote E, Van Eyk JE.

Methods. 2013 Jun 15;61(3):304-12. doi: 10.1016/j.ymeth.2013.03.006. Epub 2013 Mar 22.

19.

ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.

Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Stine WB, Manelli A, Sullivan P, Pasternak JF, LaDu MJ.

Neurobiol Dis. 2005 Feb;18(1):75-82.

PMID:
15649697
20.

Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.

Huang Y.

Biochem Soc Trans. 2011 Aug;39(4):924-32. doi: 10.1042/BST0390924.

PMID:
21787325

Supplemental Content

Support Center